Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Clinical Applications & Clinical Translation of Tissue Engineering

Roger Kamm's Biography

Roger Kamm, Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)

Kamm is currently the Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering at MIT, where he has served on the faculty since 1978. Kamm has long been instrumental in developing research activities at the interface of biology and mechanics, formerly in cell and molecular mechanics, and now in engineered living systems. Current interests are in developing models of healthy and diseased organ function using microfluidic technologies, with a focus on vascularization. Kamm has fostered biomechanics as Chair of the US National Committee on Biomechanics (2006-2009) and of the World Council on Biomechanics (2006-2010). Kamm currently directs the NSF Science and Technology Center on Emergent Behaviors of Integrated Cellular Systems. He is the 2010 recipient of the ASME Lissner Medal (American Society of Mechanical Engineering) and the 2015 recipient of the Huiskes Medal (European Society of Biomechanics), both for lifetime achievements, and is the inaugural recipient of the ASME Nerem Medal for mentoring and education. He was elected to the National Academy of Medicine in 2010. Kamm is co-founder of two companies, Cardiovascular Technologies and AIM Biotech, a manufacturer of microfluidic systems for 3D culture.

Roger Kamm Image

Using Microfluidics to Grow Perfusable Vascular Networks

Monday, 9 February 2015 at 15:30

Add to Calendar ▼2015-02-09 15:30:002015-02-09 16:30:00Europe/LondonUsing Microfluidics to Grow Perfusable Vascular

For years, one of the major hurdles in the creation of engineered tissues was the unmet need for a microvascular network.  Recently, several groups have reported the development of microfluidic systems incorporating 3D co-culture of endothelial cells and fibroblasts to produce perfusable networks of microvessels, paving the way for more complex systems with other cell types for specific organ or tissue functions.  These in vitro systems can be maintained long-term, raising the prospect of generating complete tissues in vitro for various purposes including organs for implantation or non-medical applications.  Several challenges yet need to be addressed, including the control of network morphology and stabilization of the networks once established. Both the current state-of-the-art and the directions of future research will be addressed.

Add to Calendar ▼2015-02-09 00:00:002015-02-10 00:00:00Europe/LondonClinical Applications and Clinical Translation of Tissue